Key facts
- This page summarizes Jeffrey Theiler's Form 4 filing for Physicians Realty Trust.
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 22 Jan 2024, 17:02.
Jeffrey Theiler - 18 Jan 2024 Form 4 Insider Report for Physicians Realty Trust
- Reporting relationship
- EVP - CFO
- Issuer ticker
- N/A
- Reported as of
- 18 Jan 2024
- Net transaction value
- -$409,090
- SEC form
- 4
- Accepted by SEC
- 22 Jan 2024, 17:02:53 UTC
- Prior SEC filing
- 03 Mar 2023
- Next SEC filing
- 01 Mar 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Christopher M. Bartoli, as attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jeffrey Theiler filed Form 4 for Physicians Realty Trust on 22 Jan 2024.
Change
- Previous filing in this sequence was filed on 03 Mar 2023.
- Current net transaction value: -$409,090.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DOC
transaction
Common shares, $0.01 par value
Options Exercise
- Transaction value
- Shares
- +70,972
- Change %
- +21%
- Price
- Shares after
- 405,998
- Date
- 18 Jan 2024
- Ownership
- Direct
- Footnotes
- F1, F2
DOC
transaction
Common shares, $0.01 par value
Tax liability
- Transaction value
- $409,090
- Shares
- -31,590
- Change %
- -7.8%
- Price
- $12.95
- Shares after
- 374,408
- Date
- 18 Jan 2024
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
DOC
transaction
Derivative
2021 Performance Based Restricted Share Unit Grant
Options Exercise
- Transaction value
- $0
- Shares
- -35,700
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 18 Jan 2024
- Ownership
- Direct
- Underlying class
- Common shares, $0.01 par value
- Underlying amount
- 35,700
- Exercise price
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Represents vesting of the 2021 Performance Based Restricted Share Units granted on March 1, 2021 under the Issuer's Equity Incentive Plan (the "Plan"). Subject to the terms of the grant, the Reporting Person received 70,972 common shares upon vesting.
Footnote F2
Includes 1,733 shares acquired under the Issuer's Employee Stock Purchase Plan (the "ESPP") on June 30, 2023.
Footnote F3
On March 1, 2021, the Reporting Person was granted 35,700 performance share units under the Issuer's Plan, which represent the "target" number of shares underlying the performance share units. Subject to the terms of the grant, the Reporting Person received 70,972 common shares upon vesting.